---
title: "Lianhuan Pharma's Hypertension Drug Gets Registration Certificate"
date: "2025-02-10 13:06:38"
summary: "Jiangsu Lianhuan Pharmaceutical's  olmesartan medoxomil amlodipine tablets received a drug registration certificate from the Chinese drug administration, according to a Shanghai Stock Exchange disclosure on Feb. 8. The drug is used to treat essential hypertension, the pharmaceutical company said. The company's shares rose less than 2% in recent trade."
categories:
  - "MT Newswires"
lang:
  - "en"
translations:
  - "en"
tags:
  - "MT Newswires"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

Jiangsu Lianhuan Pharmaceutical's olmesartan medoxomil amlodipine tablets received a drug registration certificate from the Chinese drug administration, according to a Shanghai Stock Exchange disclosure on Feb. 8.

The drug is used to treat essential hypertension, the pharmaceutical company said.

The company's shares rose less than 2% in recent trade.

[MT Newswires](https://www.tradingview.com/news/mtnewswires.com:20250210:G2465427:0/)
